Scientists looking at the antiviral mechanisms of two previously
identified human monoclonal antibodies have found they potentially inhibit chikungunya virus (CHIKV) at multiple stages of infection.
Scientists looking at the antiviral mechanisms of two previously
identified human monoclonal antibodies have found they potently inhibit chikungunya virus (CHIKV) at multiple stages of infection.
Not exact matches
Rational design of envelope
identifies broadly neutralizing
human monoclonal antibodies to HIV - 1.